Iron deficiency anemia secondary to blood loss (chronic)
ICD-10 D50.0 is a billable code used to indicate a diagnosis of iron deficiency anemia secondary to blood loss (chronic).
Iron deficiency anemia (IDA) is a common type of anemia that occurs when the body lacks sufficient iron to produce hemoglobin, the protein in red blood cells that carries oxygen. D50.0 specifically refers to IDA that is secondary to chronic blood loss, which can occur due to various conditions such as gastrointestinal bleeding, heavy menstrual periods, or chronic hemolysis. Chronic blood loss leads to a gradual depletion of iron stores, resulting in decreased hemoglobin levels and subsequent anemia. Patients may present with symptoms such as fatigue, weakness, pallor, and shortness of breath. Diagnosis typically involves a complete blood count (CBC), serum ferritin levels, and possibly additional tests to identify the source of blood loss. Treatment focuses on addressing the underlying cause of the blood loss, along with iron supplementation to replenish iron stores and improve hemoglobin levels. Monitoring and follow-up are essential to ensure effective management and to prevent recurrence.
Detailed lab results, history of blood loss, and treatment plans.
Patients with chronic gastrointestinal bleeding or heavy menstrual cycles.
Ensure comprehensive documentation of iron studies and response to treatment.
Endoscopy reports, biopsy results, and history of gastrointestinal symptoms.
Patients presenting with anemia and gastrointestinal complaints.
Document any findings that may indicate a source of chronic blood loss.
Used to diagnose anemia and monitor treatment response.
Document the reason for the CBC and any relevant clinical findings.
Hematology specialists should ensure that all lab results are included in the patient's record.
D50.0 is primarily caused by chronic blood loss, which can result from various conditions such as gastrointestinal bleeding or heavy menstrual periods.
Diagnosis involves a complete blood count (CBC), serum ferritin levels, and clinical evaluation to identify the source of blood loss.
Treatment includes addressing the underlying cause of blood loss and iron supplementation to restore iron levels and improve hemoglobin.
